{"changes":[],"country":"US","description":"Solve Therapeutics is a clinical-stage biopharmaceutical company developing antibody-drug conjugates for solid tumors. It serves patients with cancers driven by selectively expressed tumor antigens, with leads SLV-154 and SLV-324 in Phase 1 trials. Its CloakLink hydrophilic linker improves ADC stability and pharmacokinetics.","domain":"solvetherapeutics.com","employees":null,"founded":2022,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":32.71742,"lng":-117.162772,"location":"San Diego","name":"Solve Therapeutics","rounds":[{"amountQuarantined":false,"amountUsd":120000000,"currency":"USD","date":"2025-11-19","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"series-a","url":null}],"slug":"solvetherapeutics-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"solvetherapeutics.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://solvetherapeutics.com"},{"fact":"description","publisher":"solvetherapeutics.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://solvetherapeutics.com"}],"stage":"series-a","techStack":["Nginx","All in One SEO pro 4.9.1","Google Analytics","Google Tag Manager","Font Awesome","jQuery Migrate 3.4.1","imagesLoaded 5.0.0","Elementor 3.33.2","DoubleClick Floodlight","Complianz","Vercel Speed Insights","Python"],"totalRaisedUsd":120000000,"updatedAt":"2026-05-07"}